Dies ist eine Übersichtsseite mit Metadaten zu dieser wissenschaftlichen Arbeit. Der vollständige Artikel ist beim Verlag verfügbar.
Human-centered AI as a framework guiding the development of image-based diagnostic tools in oncology: a systematic review
3
Zitationen
5
Autoren
2024
Jahr
Abstract
Background: Artificial intelligence diagnostic tools (AIDTs) in oncology show high image classification accuracy but limited clinical adoption. Their adoption could be enhanced by (i) using user feedback during the software design, (ii) demonstrating that AIDTs improve the user's decisions, and (iii) providing explanations of AI decisions tailored to the user, three aspects central to human-centered AI (HCAI). This review assesses these three aspects in AIDTs for oncology in general, exemplifying its concepts in the established field of skin cancer diagnostics as a specific use case. Materials and methods: We carried out three Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA) searches using PubMed and ScienceDirect, limiting the results to articles published from 2019 to 2024. The first search focused on articles that used user feedback to develop AIDTs. The second search addressed whether AIDT improves dermatologists' decisions. The third search targeted explainable AI in skin cancer. Results: = 26), with papers assessing the user's preference for explainable AI (XAI) methods or the impact of XAI on the user's trust in AI diagnosis. Conclusions: User feedback has been used to develop AIDTs tailored to clinicians' needs. Evidence shows that AIDTs can improve clinicians' decisions. This, combined with XAI, increases clinicians' trust in AIDTs, potentially favoring their widespread usage.
Ähnliche Arbeiten
Dermatologist-level classification of skin cancer with deep neural networks
2017 · 13.497 Zit.
Tumor Angiogenesis: Therapeutic Implications
1971 · 10.112 Zit.
Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation
2011 · 7.674 Zit.
Pembrolizumab versus Ipilimumab in Advanced Melanoma
2015 · 5.809 Zit.
Overall Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma
2017 · 5.362 Zit.